Cosmos Health weekly recap: Cana Labs orders, CCX0722 patents
Cana Labs won five-year Target Pharma orders, lifting Cosmos Health’s book to 32.7M units; Cosmos Health secured CCX0722 patents and signed ROSARTIA and plant investment items to expand production, targeting >$10M annual profit.